Intellipharmaceutics International Inc IPCIQ

Did you notice?

[Nogah3]

Hi all,

I spoke about this company's advancement (licensing out 3 drugs) for Q4 and its even greater potential which unfortunately the market does not understand. The final point I wished to raise awareness of was the price manipulation this morning.

There was one shareholder with >270K shares who entered extremely low ask prices this morning before market open. Of course, with the news that the the committee wasn't supporting the company's Oxycodone formulation, seeing ask prices in the range of 12 to 20 cents must have been devestating. I am sorry for those who felt pressured to sell by this malicious trick. That person gobbled hundreds of thousands of shares at a fifth of their value.

For the rest of you still holding shares, I would advise that you keep them and not listen to those who tell you to cut your losses. Why? Because as stated before, the company has made 3 recent signings that will grow revenue and this is not a company that has its eggs in one basket. PLUS, for those who went to the company's website to have a look at their pipeline, you'll notice that their real big gun (pregabalin, Market size >$5 Bil) is yet to come along with a few others in the making.

TL;DR -> hold your shares and you'll see the price slowly but surely rebound.
Take care

[FredZarfloon]

In 2015 "FDA completed its review of the (Regabatin) IND application and provided constructive input that we will use towards further development of the program." Looks like it ain't doing much - and a search for Regabatin at US clinical trials turns up nothing.

[bigkagan]

this dummy Odidi put all his money on the Oxy Aximiris and totally neglected Regabatin. He thought that if he monkeys around with Aximiris a little bit he'll be able to fool FDA to grant the permit but it didn't work, the AdCom don't want any Oxy drugs no more, period. There is still a faint hope that FDA will approve it with some conditions because it has those safety features

[bigkagan]

the FDA may feel guilty that it told Odidi to do more checking on the oral and nasal aspects of Aximiris which he did and then it rejected it anyway. Can somebody say "lawsuit"?

[bigkagan]

if FDA every time does what AdCom decides why do we need FDA at all, let AdCom issue all the drug permits, we'll save millions on all those FDA salaries, ha

[bigkagan]

there could be a conflict between FDA and the AdCom because a year ago FDA practically assured IPCI that if it tweeks the oral and nasal safety features the approval is assured - now if FDA rejects Aximiris because it's against opium pills in principal this would look like it was dealing with IPCI in bad faith. The AdCom guys could be either against Oxy on moral grounds or being connected to